Cargando…
Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
Breast cancer is a major public health problem which treatment needs new pharmacological options. In the last decades, during the postgenomic era new theoretical and technological tools that give us novel and promising ways to address these problems have emerged. In this work, we integrate several t...
Autores principales: | Mejía-Pedroza, Raúl A., Espinal-Enríquez, Jesús, Hernández-Lemus, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104565/ https://www.ncbi.nlm.nih.gov/pubmed/30158869 http://dx.doi.org/10.3389/fphar.2018.00905 |
Ejemplares similares
-
Network Modularity in Breast Cancer Molecular Subtypes
por: Alcalá-Corona, Sergio Antonio, et al.
Publicado: (2017) -
Transcriptional Network Architecture of Breast Cancer Molecular Subtypes
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2016) -
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2021) -
Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes
por: Serrano-Carbajal, Erandi A., et al.
Publicado: (2020) -
CNVs in 8q24.3 do not influence gene co-expression in breast cancer subtypes
por: Hernández-Gómez, Candelario, et al.
Publicado: (2023)